Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ardent Health (ARDT) EBIT (2023 - 2025)

Historic EBIT for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to -$278.1 million.

  • Ardent Health's EBIT fell 4275.73% to -$278.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$708.2 million, marking a year-over-year increase of 1300.29%. This contributed to the annual value of -$670.1 million for FY2024, which is 2040.04% up from last year.
  • Per Ardent Health's latest filing, its EBIT stood at -$278.1 million for Q3 2025, which was down 4275.73% from -$148.6 million recorded in Q2 2025.
  • In the past 5 years, Ardent Health's EBIT registered a high of -$96.8 million during Q4 2024, and its lowest value of -$278.1 million during Q3 2025.
  • Over the past 3 years, Ardent Health's median EBIT value was -$189.9 million (recorded in 2023), while the average stood at -$191.1 million.
  • Its EBIT has fluctuated over the past 5 years, first soared by 5979.41% in 2024, then crashed by 4275.73% in 2025.
  • Quarter analysis of 3 years shows Ardent Health's EBIT stood at -$240.9 million in 2023, then skyrocketed by 59.79% to -$96.8 million in 2024, then tumbled by 187.15% to -$278.1 million in 2025.
  • Its EBIT was -$278.1 million in Q3 2025, compared to -$148.6 million in Q2 2025 and -$184.7 million in Q1 2025.